肯·费舍尔的战略动向：AstraZeneca PLC 领衔投资组合加仓

Exploring the Latest 13F Filing and Investment Shifts Ken Fisher (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2026, providing insights into his investment moves during this period. Ken Fisher (Trades, Portfolio) is the Chief Executive Officer and Chief Investment Officer of Fisher Investments.

该内容为新闻快讯，正文已简化。